Controlled Study for Prolonged Chemotherapy, Immunotherapy, and Chemotherapy Plus Immunotherapy as an Adjuvant to Surgery in Malignant Melanoma (Trial 6): Preliminary Report

作者： U. Veronesi , G. Beretta

关键词: Melanoma 、 In patient 、 Minimal residual disease 、 Adjuvant 、 Preliminary report 、 Immunotherapy 、 Surgery 、 Medicine 、 Cutaneous melanoma 、 Chemotherapy 、 Internal medicine 、 Oncology

摘要: The International Group for the Clinical Study of Melanoma started in 1974 a controlled study to evaluate effects long-term adjuvant therapies on disease-free period and survival patients radically operated primary or recurrent high-risk cutaneous melanoma. Preliminary data were presented 1977 Washington [1].